(搜尋結果 430 項結果)
排序：
Hepatic Encephalopathy - Pipeline Review, H1 2020
2020/01/14
Hepatic Encephalopathy - Pipeline Review, H1 2020SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatic En.. more USD 2,000
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H1 2020
2020/01/14
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H1 2020SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline gu.. more USD 2,500
Down Syndrome - Pipeline Review, H1 2020
2020/01/14
Down Syndrome - Pipeline Review, H1 2020SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Down Syndrome - Pip.. more USD 2,000
Prader-Willi Syndrome (PWS) - Pipeline Review, H1 2020
2020/01/14
Prader-Willi Syndrome (PWS) - Pipeline Review, H1 2020SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prade.. more USD 2,000
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2020
2020/01/14
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2020SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease .. more USD 2,000
Nocturia - Pipeline Review, H1 2020
2020/01/14
Nocturia - Pipeline Review, H1 2020SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Pipeline Revi.. more USD 2,000
Urinary Incontinence - Pipeline Review, H1 2020
2020/01/14
Urinary Incontinence - Pipeline Review, H1 2020SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Inco.. more USD 2,000
Iron Deficiency Anemia - Pipeline Review, H1 2020
2020/01/14
Iron Deficiency Anemia - Pipeline Review, H1 2020SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Iron Defic.. more USD 2,000
Secondary Hyperparathyroidism - Pipeline Review, H1 2020
2020/01/14
Secondary Hyperparathyroidism - Pipeline Review, H1 2020SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sec.. more USD 2,000
Myasthenia Gravis - Pipeline Review, H1 2020
2020/01/14
Myasthenia Gravis - Pipeline Review, H1 2020SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myasthenia Grav.. more USD 2,000